Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Epidemiology of Parkinson's disease

de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

LXXIII.—Oxidation of tartaric acid in presence of iron

Fenton, H. J. H. (1894) · J. Chem. Soc., Trans. · doi:10.1039/ct8946500899 · Cited by 3,179 · see citing works

An Essay on the Shaking Palsy

Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,684 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Oxidative stress in neurodegeneration: Cause or consequence?

Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · see citing works

Iron, brain ageing and neurodegenerative disorders

Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · see citing works

Oxidation of tartaric acid in presence of iron

Fenton, H. J. H. (1894) · Journal of the Chemical Society (Resumed) · Cited by 1,498 · see citing works

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377 · see citing works

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

Blum, D. L., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A., Sadoul, R., & Verna, J. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Protocol for the MPTP mouse model of Parkinson's disease

Jackson-Lewis, V. R., & Przedborski, S. (2007) · Nature Protocols · doi:10.1038/nprot.2006.342 · Cited by 1,118 · see citing works

Neurobiology of Zinc and Zinc-Containing Neurons

Frederickson, C. J. (1989) · International review of neurobiology · doi:10.1016/s0074-7742(08)60279-2 · Cited by 1,083 · see citing works

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043 · see citing works

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010 · see citing works

Copper, oxidative stress, and human health

Uriu‐Adams, J. Y., & Keen, C. L. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.015 · Cited by 981 · see citing works

Pharmacological Actions of 6-Hydroxydopamine

Kostrzewa, R. M., & Jacobowitz, D. M. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06677-3 · Cited by 819 · see citing works

Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP

Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803 · see citing works

Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway

Deumens, R., Blokland, A., & Prickaerts, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7891 · Cited by 760 · see citing works

Zinc in the physiology and pathology of the CNS

Sensi, S. L., Paoletti, P., Bush, A. I., & Sekler, I. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2734 · Cited by 759 · see citing works

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

Duty, S., & Jenner, P. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 758 · see citing works

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725 · see citing works

Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death

Bains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 716 · see citing works

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Gerlach, M., Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 704 · see citing works

Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease

Duce, J. A., Tsatsanis, A., Cater, M. A., James, S., Robb, E. L., Wikhe, K., Leong, S. L., Perez, K. A., Johanssen, T., Greenough, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.014 · Cited by 682 · see citing works

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672 · see citing works

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine · doi:10.1038/nm.2613 · Cited by 594 · see citing works

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease

Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M., & Mayer, R. J. (1988) · The Journal of Pathology · doi:10.1002/path.1711550105 · Cited by 539 · see citing works

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 506 · see citing works

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495 · see citing works

The role of tau in neurodegeneration

Gendron, T. F., & Petrucelli, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-13 · Cited by 478 · see citing works

Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445 · see citing works

Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons

Hantraye, P., Brouillet, E., Ferrante, R. J., Palfi, S., Dolan, R., Matthews, R. T., & Beal, M. F. (1996) · Nature Medicine · doi:10.1038/nm0996-1017 · Cited by 422 · see citing works

Iron trafficking inside the brain

Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 421 · see citing works

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Ara, J. E., Przedborski, S., Naini, A., Jackson-Lewis, V. R., Trifiletti, R. R., Horwitz, J., & Ischiropoulos, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7659 · Cited by 414 · see citing works

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409 · see citing works

Transcranial sonography in movement disorders

Berg, D., Godau, J., & Walter, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70239-4 · Cited by 372 · see citing works

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 356 · see citing works

The role of α-synuclein in Parkinson's disease: insights from animal models

Lad, E. M., Dass, B., Collier, T. J., Kordower, J. H., & Steece‐Collier, K. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1199 · Cited by 349 · see citing works

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration

Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P. J., Altshuler, L. L., Carter, M., Huang, D., Edwards, N. J., & Mintz, J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 343 · see citing works

Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease?

Thiruchelvam, M. J., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory‐Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324 · see citing works

The possible role of iron in the etiopathology of parkinson's disease

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1993) · Movement Disorders · doi:10.1002/mds.870080102 · Cited by 301 · see citing works

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299 · see citing works

Copper complexes as therapeutic agents

Duncan, C., & White, A. R. (2011) · Metallomics · doi:10.1039/c2mt00174h · Cited by 293 · see citing works

MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

Przedborski, S., Tieu, K., Perier, C., & Vila, M. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041771.66775.d5 · Cited by 289 · see citing works

Similarities between Neurologic Effects of L-Dopa and of Apomorphine

Cotzias, G. C., Papavasiliou, P. S., Fehling, C., Kaufman, B., & Mena, I. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197001012820107 · Cited by 272 · see citing works

Selegiline slows the progression of the symptoms of Parkinson disease

Pålhagen, S., Heinonen, E. H., Hägglund, J., Kaugesaar, T., Mäki-Ikola, O., Palm, R., & the Swedish Parkinson Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000204007.46190.54 · Cited by 271 · see citing works

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

Zhang‐James, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 261 · see citing works

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246 · see citing works

A 6-hydroxydopamine-induced selective parkinsonian rat model

Perese, D. A., Ulman, J. N., Viola, J. J., Ewing, S. E., & Bankiewicz, K. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90597-0 · Cited by 241 · see citing works

The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review

Moos, T., & Morgan, E. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.002 · Cited by 234 · see citing works

MPTP: current concepts and controversies.

Langston, J. W., & Irwin, I. (1986) · PubMed · Cited by 234 · see citing works

RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASE

Pall, H., Blake, D. R., Gutteridge, J. M. C., Williams, A. C., Lunec, J., Hall, M., & Taylor, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90827-0 · Cited by 230 · see citing works

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson??s Disease

Jellinger, K. A. (1999) · Drugs & Aging · doi:10.2165/00002512-199914020-00004 · Cited by 218 · see citing works

IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects

Johannessen, J. N., Chiueh, C. C., Burns, R. S., & Markey, S. P. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90062-1 · Cited by 211 · see citing works

Axonal sprouting following lesions of the rat substantia nigra

Finkelstein, D. I., Stanić, D., Parish, C. L., Tomas, D., Dickson, K. A., & Horne, M. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00009-9 · Cited by 201 · see citing works

The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199 · see citing works

MPTP

Langston, J. W., & Irwin, I. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198612000-00001 · Cited by 199 · see citing works

Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol

Meredith, G. E., Totterdell, S., Potashkin, J. A., & Surmeier, D. J. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.012 · Cited by 193 · see citing works

Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.<i>In vivo</i>selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03341.x · Cited by 185 · see citing works

Iron metabolism in Parkinsonian syndromes

Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 185 · see citing works

The start of a long debate on the Warnock report.

Deitch, R. (1984) · PubMed · Cited by 185 · see citing works

Animal models of tremor

Wilms, H., Sievers, J., & Deuschl, G. (1999) · Movement Disorders · doi:10.1002/1531-8257(199907)14:4 · Cited by 171 · see citing works

Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls.

Thomas, C. E., & Aust, S. D. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69271-3 · Cited by 167 · see citing works

Iron accumulation in the substantia nigra in rats visualized by ultrasound

Berg, D., Grote, C., Rausch, W., Mäurer, M., Wesemann, W., Riederer, P. F., & Becker, G. (1999) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(99)00046-0 · Cited by 165 · see citing works

Metals in our minds: therapeutic implications for neurodegenerative disorders

Doraiswamy, P. M., & Finefrock, A. E. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00809-9 · Cited by 161 · see citing works

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

Lan, J., & Jiang, D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 160 · see citing works

Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc

Maret, W. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00173-r · Cited by 160 · see citing works

Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra

Peng, J., Stevenson, F. F., Doctrow, S. R., & Andersen, J. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500984200 · Cited by 159 · see citing works

Expression and regulation of brain metallothionein

Ebadi, M., Iversen, P. L., Hao, R., CERUTIS, D. R., Rojas, P., Happe, H. K., Murrin, L. C., & Pfeiffer, R. F. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00164-p · Cited by 157 · see citing works

In Vitro Studies of Ferritin Iron Release and Neurotoxicity

Double, K. L., Maywald, M., Schmittel, M., Riederer, P. F., & Gerlach, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062492.x · Cited by 152 · see citing works

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in parkinson's disease: An in situ hybridization study

Javoy-Agid, F., Hirsch, É. C., Dumas, S., Duyckaerts, C. J., Mallet, J. J., & Agid, Y. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90389-l · Cited by 146 · see citing works

Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age

Kaur, D., Peng, J., Chinta, S. J., Rajagopalan, S., Monte, D. A. D., Cherny, R. A., & Andersen, J. K. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.003 · Cited by 146 · see citing works

Oxidative stress and brain aging: is zinc the link?

Frazzini, V., Rockabrand, E., Mocchegiani, E., & Sensi, S. L. (2006) · Biogerontology · doi:10.1007/s10522-006-9045-7 · Cited by 140 · see citing works

Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

Kupsch, A. R., Sautter, J., Götz, M. E., Breithaupt, W., Schwarz, J., Youdim, M. B. H., Riederer, P. F., Gerlach, M., & Oertel, W. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170018 · Cited by 139 · see citing works

Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1

Innamorato, N. G., Jaźwa, A., Rojo, A. I., García, C., Fernández‐Ruíz, J., Grochot‐Przeczek, A., Stachurska, A., Józkowicz, A., Dulak, J., & Cuadrado, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011838 · Cited by 138 · see citing works

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration

Dexter, D. T., Statton, S. A., Whitmore, C. L., Freinbichler, W., Weinberger, P., Tipton, K. F., Corte, L., Ward, R. J., & Crichton, R. R. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0531-3 · Cited by 137 · see citing works

Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis

Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137 · see citing works

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

Mochizuki, H., Imai, H., Endo, K., Yokomizo, K., Murata, Y., Hattori, N., & Mizuno, Y. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90462-6 · Cited by 132 · see citing works

Neuroprotective actions of selegiline

Ebadi, M., Sharma, S., Shavali, S., & Refaey, H. E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10148 · Cited by 132 · see citing works

Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study

Sotelo, C., Javoy-Agid, F., Agid, Y., & Glowinski, J. (1973) · Brain Research · doi:10.1016/0006-8993(73)90001-2 · Cited by 131 · see citing works

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126 · see citing works

Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention

Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3768-11.2011 · Cited by 125 · see citing works

6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation

Monteiro, H. P., & Winterbourn, C. C. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90512-1 · Cited by 125 · see citing works

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

Jiang, H. F., Song, N., Xu, H., Zhang, S., Wang, J., & Xie, J. (2010) · Cell Research · doi:10.1038/cr.2010.20 · Cited by 122 · see citing works

Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease

Adlard, P. A., Bica, L., White, A. R., Nurjono, M., Filiz, G., Crouch, P. J., Donnelly, P. S., Cappai, R., Finkelstein, D. I., & Bush, A. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017669 · Cited by 120 · see citing works

Copper binding regulates intracellular alpha‐synuclein localisation, aggregation and toxicity

Wang, X., Moualla, D., Wright, J. A., & Brown, D. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06638.x · Cited by 120 · see citing works

Quantitative elemental bio-imaging of Mn, Fe, Cu and Zn in 6-hydroxydopamine induced Parkinsonism mouse models

Hare, D. J., Reedy, B. J., Grimm, R., Wilkins, S., Volitakis, I., George, J. L., Cherny, R. A., Bush, A. I., Finkelstein, D. I., & Doble, P. (2008) · Metallomics · doi:10.1039/b816188g · Cited by 120 · see citing works

Altered systemic iron metabolism in Parkinson's disease

Logroscino, G., Marder, K. S., Graziano, J. H., Freyer, G. A., Slavkovich, V. N., LoIacono, N. J., Cote, L. J., & Mayeux, R. P. (1997) · Neurology · doi:10.1212/wnl.49.3.714 · Cited by 118 · see citing works

Obligatory Role for Complex I Inhibition in the Dopaminergic Neurotoxicity of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Richardson, J. R., Caudle, W. M., Guillot, T. S., Watson, J. L., Nakamaru‐Ogiso, E., Seo, B. B., Sherer, T., Greenamyre, J. T., Yagi, T., Matsuno‐Yagi, A., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl133 · Cited by 117 · see citing works

Copper, Zinc, and the Metallobiology of Alzheimer Disease

Bush, A. I. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00005 · Cited by 117 · see citing works

Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease

Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116 · see citing works

Benefits and Risks of Deferiprone in Iron Overload in Thalassaemia and Other Conditions

Kontoghiorghes, G. J., Neocleous, K., & Kolnagou, A. (2003) · Drug Safety · doi:10.2165/00002018-200326080-00003 · Cited by 112 · see citing works

Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease

Song, N., Wang, J., Jiang, H. F., & Xie, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.004 · Cited by 109 · see citing works

THE ANTIOXIDANT PROPERTIES OF ZINC AND METALLOTHIONEIN

Ebadi, M., Leuschen, M. P., Refaey, H. E., Hamada, F., & Rojas, P. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00116-6 · Cited by 108 · see citing works

Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease

Ebadi, M., Brown‐Borg, H. M., Refaey, H. E., Singh, B. B., Garrett, S. H., Shaik, S., & Sharma, S. K. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.011 · Cited by 108 · see citing works

Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease

Xie, W., Li, X., Li, C., Zhu, W., Jankovic, J. J., & Le, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06914.x · Cited by 105 · see citing works

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

Lhermitte, J., Kraus, W. M., & McAlpine, D. (1924) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-5.19.195 · Cited by 103 · see citing works

Coenzyme Q10 Provides Neuroprotection in Iron-Induced Apoptosis in Dopaminergic Neurons

Kooncumchoo, P., SHARMA, S. K., Porter, J. E., Govitrapong, P., & Ebadi, M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:2:125 · Cited by 100 · see citing works

Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease

Lan, J., & Jiang, D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291883 · Cited by 100 · see citing works

Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker

Berg, D., Hochstrasser, H., Schweitzer, K. J., & Rieß, O. (2006) · Neurotoxicity Research · doi:10.1007/bf03033302 · Cited by 98 · see citing works

Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity

Lee, D. W., Rajagopalan, S., Siddiq, A., Gwiazda, R. H., Yang, L., Beal, M. F., Ratan, R. R., & Andersen, J. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000638 · Cited by 97 · see citing works

Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

Castellani, R. J., Honda, K., Zhu, X., Cash, A., Nunomura, A., Perry, G. L., & Smith, M. A. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.002 · Cited by 97 · see citing works

Dopamine efflux by MPTP and hydroxyl radical generation

Obata, T. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-001-0683-2 · Cited by 96 · see citing works

Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6‐OHDA‐lesioned rats

Wang, J., Jiang, H. F., & Xie, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05515.x · Cited by 95 · see citing works

The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals

Poirier, J., Donaldson, J., & Barbeau, A. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91639-0 · Cited by 95 · see citing works

MPTP Produces Differential Oxidative Stress and Antioxidative Responses in the Nigrostriatal and Mesolimbic Dopaminergic Pathways

Hung, H.-C., & Lee, E. H. Y. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00206-2 · Cited by 95 · see citing works

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease

Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M., & Rios, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00221-9 · Cited by 92 · see citing works

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

Zhang, X., Xie, W., Qu, S., Pan, T., Wang, X., & Le, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.150 · Cited by 87 · see citing works

No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism

Halliday, G. M., Herrero, M. T., Murphy, K., McCann, H., Ros‐Bernal, F., Barcia, C., Mori, H., Blesa, F. J., & Obeso, J. A. (2009) · Movement Disorders · doi:10.1002/mds.22481 · Cited by 86 · see citing works

Microglia activation is related to substantia nigra echogenicity

Berg, D., Godau, J., Riederer, P. F., Gerlach, M., & Arzberger, T. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0504-6 · Cited by 83 · see citing works

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells

Molina‐Holgado, F., Gaeta, A., Francis, P. T., Williams, R. J., & Hider, R. C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05332.x · Cited by 82 · see citing works

Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins

Wang, J., Xu, H., Yang, H., Du, X., Jiang, H. F., & Xie, J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.003 · Cited by 79 · see citing works

Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease

Kurosaki, R., Muramatsu, Y., Kato, H., & Araki, T. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.006 · Cited by 78 · see citing works

Iron and ferritin in substantia nigra in Parkinson's disease.

Jellinger, K. A., Kienzl, E., Rumpelmaier, G., Paulus, W., Riederer, P., Stachelberger, H., Youdim, M. B. H., & Ben‐Shachar, D. (1993) · PubMed · Cited by 78 · see citing works

Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain

Hare, D. J., George, J. L., Grimm, R., Wilkins, S., Adlard, P. A., Cherny, R. A., Bush, A. I., Finkelstein, D. I., & Doble, P. (2010) · Metallomics · doi:10.1039/c0mt00039f · Cited by 75 · see citing works

Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

Lau, Y., Trobough, K. L., Crampton, J. M., & Wilson, J. A. (1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90898-v · Cited by 75 · see citing works

Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30

Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9070-9 · Cited by 75 · see citing works

Metal‐based Neurodegeneration

Crichton, R. R., & Ward, R. J. (2005) · Wiley eBooks · doi:10.1002/0470022574 · Cited by 73 · see citing works

Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

Lv, Z., Jiang, H. F., Xu, H., Song, N., & Xie, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0434-3 · Cited by 67 · see citing works

Copper-Triggered Aggregation of Ubiquitin

Arnesano, F., Scintilla, S., Calò, V., Bonfrate, E., Ingrosso, C., Losacco, M., Pellegrino, T., Rizzarelli, E., & Natile, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007052 · Cited by 66 · see citing works

Role of dietary iron restriction in a mouse model of Parkinson's disease

Levenson, C. W., Cutler, R. G., Ladenheim, B., Cadet, J. L., Hare, J., & Mattson, M. P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.014 · Cited by 64 · see citing works

Oxidative damage to ferritin by 5-aminolevulinic acid

Rocha, M. E. M., Dutra, F., Bandy, B., Baldini, R. L., Gomes, S. L., Faljoni‐Alário, A., Liria, C. W., Teresa, M., Miranda, M., & Bechara, E. J. H. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00633-1 · Cited by 64 · see citing works

Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys

He, Y., Thong, P. S. P., Lee, T. T., Leong, S. K., Mao, B. Y., Dong, F., & Watt, F. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00385-x · Cited by 62 · see citing works

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation

Meredith, G. E., Halliday, G. M., & Totterdell, S. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.001 · Cited by 57 · see citing works

Serum levels of zinc and copper in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Fernández–Calle, P., Martı́nez, M., Herrero, E., Molina, J. A., Vázquez, A., & Codoceo, R. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90127-7 · Cited by 54 · see citing works

Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress

Mackenzie, E. L., Ray, P. D., & Tsuji, Y. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.031 · Cited by 53 · see citing works

Diethyldithiocarbamate Potentiates the Neurotoxicity of In Vivo l‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine and of In Vitro 1‐Methyl‐4‐Phenylpyridinium

Miller, D. B., Reinhard, J. F., Daniels, A. J., & O'Callaghan, J. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03784.x · Cited by 53 · see citing works

Rg1 protects iron‐induced neurotoxicity through antioxidant and iron regulatory proteins in 6‐OHDA‐treated MES23.5 cells

Xu, H., Jiang, H. F., Wang, J., & Xie, J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22885 · Cited by 53 · see citing works

Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration

Zhu, W., Li, X., Xie, W., Luo, F., Kaur, D., Andersen, J. K., Jankovic, J. J., & Le, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.024 · Cited by 53 · see citing works

Metal specificity of an iron-responsive element in Alzheimer’s APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator

Bandyopadhyay, S., Huang, X., Cho, H. K., Greig, N. H., Youdim, M. B. H., & Rogers, J. T. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_25 · Cited by 51 · see citing works

Neuroprotective Effect of Acute and Chronic Administration of Copper (II) Sulfate against MPP+ Neurotoxicity in Mice

Alcaraz-Zubeldia, M., Rojas, P., Boll, C., & Rı́os, C. (2001) · Neurochemical Research · doi:10.1023/a:1007680616056 · Cited by 48 · see citing works

Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex

Radunović, A., Pôrto, W. G., Zeman, S., & Leigh, P. N. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00905-1 · Cited by 48 · see citing works

Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake

Xu, H., Jiang, H. F., Wang, J., & Xie, J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.002 · Cited by 48 · see citing works

Superoxide dismutase activity and zinc and copper concentrations in Parkinson’s disease

Kocatürk, P. A., Akbostancı, M. C., Tan, F. U., & Kavas, G. Ö. (2000) · Pathophysiology · doi:10.1016/s0928-4680(00)00030-4 · Cited by 46 · see citing works

A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage

Baraibar, M. A., Barbeito, A. G., Muhoberac, B. B., & Vidal, R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.015 · Cited by 45 · see citing works

Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures

Di Monte, D. A., Schipper, H. M., Hetts, S., & Langston, J. W. (1995) · Glia · doi:10.1002/glia.440150213 · Cited by 43 · see citing works

Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells

Ajjimaporn, A., Swinscoe, J. C., Shaik, S., Govitrapong, P., & Ebadi, M. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.07.012 · Cited by 42 · see citing works

Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems

Miller, R. M., & Federoff, H. J. (2005) · The Neuroscientist · doi:10.1177/1073858405278330 · Cited by 41 · see citing works

Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment

Lee, J., Son, H. J., Choi, J. H., Cho, E., Kim, J., Chung, S. J., Hwang, O., & Koh, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.046 · Cited by 39 · see citing works

ParkDB: a Parkinson's disease gene expression database

Taccioli, C., Maselli, V., Tegner, J. N., Gómez-Cabrero, D., Altobelli, G., Emmett, W., Lescai, F., Gustincich, S., & Stupka, E. (2011) · Database · doi:10.1093/database/bar007 · Cited by 39 · see citing works

Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice

Kupershmidt, L., Amit, T., Bar‐Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.03.001 · Cited by 38 · see citing works

Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: Mechanisms by which metal chelation enhances inhibition by superoxide dismutase

Bandy, B., & Davison, A. J. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90497-8 · Cited by 38 · see citing works

Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration

Kaur, D., Rajagopalan, S., Chinta, S., Kumar, J., Di Monte, D., Cherny, R. A., & Andersen, J. K. (2007) · Brain Research · doi:10.1016/j.brainres.2006.03.006 · Cited by 36 · see citing works

Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.

Rubio-Osornio, M., Montes, S., Pérez-Severiano, F., Aguilera, P., Floriano-Sánchez, E., Monroy-Noyola, A., Rubio, C., & Ríos, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.019 · Cited by 35 · see citing works

Ceruloplasmin Protects Against Rotenone-Induced Oxidative Stress and Neurotoxicity

Hineno, A., Kaneko, K., Yoshida, K., & Ikeda, S. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0537-8 · Cited by 35 · see citing works

Depletion of Copper and Manganese in Brain after MPTP Treatment of Mice

Rı́os, C., Alvarez-Vega, R., & Rojas, P. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00160.x · Cited by 35 · see citing works

Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson’s disease

Kunikowska, G., & Jenner, P. G. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02240-6 · Cited by 35 · see citing works

Zinc rescues dopaminergic SK–N–SH cell lines from methamphetamine-induced toxicity

Ajjimaporn, A., Shaik, S., Ebadi, M., & Govitrapong, P. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.09.006 · Cited by 35 · see citing works

Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease

Carroll, C., Zeissler, M., Chadborn, N., Gibson, K., Williams, G. T., Zajicek, J., Morrison, K. E., & Hanemann, C. O. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.006 · Cited by 34 · see citing works

Manganese mimics the action of 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in rat striatal tissue slices

Hirata, Y., Kiuchi, K., & Nagatsu, T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02144-9 · Cited by 33 · see citing works

Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model

Choi, Y., Park, J.-H., & Lim, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.049 · Cited by 33 · see citing works

An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

Goto, K., Mochizuki, H., Imai, H., Akiyama, H., & Mizuno, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00284-3 · Cited by 32 · see citing works

17β-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult

Tripanichkul, W., Sripanichkulchai, K., Duce, J. A., & Finkelstein, D. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.076 · Cited by 32 · see citing works

The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice

Youdim, M. B. H., Grünblatt, E., & Mandel, S. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0499-1 · Cited by 31 · see citing works

M30, a brain permeable multi target neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models

Youdim, M. B. H. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70047-5 · Cited by 29 · see citing works

Copper ions disrupt dopamine metabolism via inhibition of V‐H+‐ATPase: a possible contributing factor to neurotoxicity

Wimalasena, D. S., Wiese, T. J., & Wimalasena, K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04362.x · Cited by 29 · see citing works

VTA neurons show a potentially protective transcriptional response to MPTP

Phani, S., Gonye, G. E., & Iacovitti, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.061 · Cited by 28 · see citing works

Metallothionein Inducers Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity in Mice

Rojas, P., & Rı́os, C. (1997) · Neurochemical Research · doi:10.1023/a:1027312901477 · Cited by 26 · see citing works

A Mechanistic Study of Proteasome Inhibition-Induced Iron Misregulation in Dopamine Neuron Degeneration

Li, X., Xie, W., Zhang, Z., Kansara, S., Jankovic, J. J., & Le, W. (2012) · Neurosignals · doi:10.1159/000332954 · Cited by 26 · see citing works

Element imaging in formalin fixed slices of human mesencephalon

Matusch, A., Bauer, A., & Becker, J. S. (2011) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2011.03.006 · Cited by 24 · see citing works

Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells

Bae, J., Kim, M., Jang, C., & Lee, S. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0216-6 · Cited by 21 · see citing works

Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells

Kobayashi, H., Oikawa, S., Umemura, S., Hirosawa, I., & Kawanishi, S. (2008) · Free Radical Research · doi:10.1080/10715760802270334 · Cited by 20 · see citing works

MPTP Decreases MT-I mRNA In Mouse Striatum

Rojas, P., Rojas‐Castañeda, J. C., Vigueras, R. M., Habeebu, S. S., Rojas, C., Rı́os, C., & Ebadi, M. (2000) · Neurochemical Research · doi:10.1023/a:1007564126478 · Cited by 19 · see citing works

Role of Lipoamide Dehydrogenase and Metallothionein on 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Neurotoxicity

Dhanasekaran, M., Albano, C. B., Pellet, L., Karuppagounder, S. S., Uthayathas, S., Suppiramaniam, V. D., Brown‐Borg, H. M., & Ebadi, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9468-9 · Cited by 19 · see citing works

Short-term manganese pretreatment partially protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Rojas, P., & R�os, C. (1995) · Neurochemical Research · doi:10.1007/bf00995386 · Cited by 19 · see citing works

Gene expression profiling of MPP+-treated MN9D cells: A mechanism of toxicity study

Wang, J., Xu, Z., Fang, H., Duhart, H. M., Patterson, T. A., & Ali, S. F. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.02.013 · Cited by 19 · see citing works

Covalent arylation of metallothionein by oxidized dopamine products: A possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival

Gauthier, M. A., Eibl, J. K., Crispo, J. A. G., & Ross, G. M. (2008) · Neurotoxicity Research · doi:10.1007/bf03033856 · Cited by 18 · see citing works

Changes of metallothionein i + ii proteins in the brain after l-methyl-4-phenylpyridinium administration in mice

Rojas, P., Hidalgo, J., Ebadi, M., & Rı́os, C. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00077-9 · Cited by 18 · see citing works

Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-hydroxydopamine Parkinson's disease mouse model by LA-ICP-MS

Sussulini, A., Matusch, A., Klietz, M., Bauer, A., Depboylu, C., & Becker, J. S. (2012) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-2012-0011 · Cited by 17 · see citing works

Functional Consequences of Iron Overload in Catecholaminergic Interactions: the Youdim Factor

Archer, T., & Fredriksson, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9358-1 · Cited by 16 · see citing works

A nuclear microscopic and histochemical study of iron concentrations and distribution in the midbrain of two age groups of monkeys unilaterally injected with MPTP

Ren, M.-Q., Ong, W., Wang, X., & Watt, F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00341-8 · Cited by 15 · see citing works

Molecular Factors Affecting the Complex Formation between Deferiprone (L1) and Cu(II)

Pashalidis, I., & Kontoghiorghes, G. J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300151 · Cited by 15 · see citing works

Copper Resistance and Accumulation in the Zygomycete Mucor rouxii

Ramírez-Salgado, P., Caracheo, S., Obregón-Herrera, A., Sosa-Luna, L., Amézquita-López, F., Mendoza-Dı́az, G., & Gutiérrez‐Corona, F. (1996) · Current Microbiology · doi:10.1007/s002849900094 · Cited by 14 · see citing works

The effect of d-penicillamine on metallothionein mRNA levels and copper distribution in mouse hepatocytes

McArdle, H. J., Kyriakou, P., Grimes, A., Mercer, J. F. B., & Danks, D. M. (1990) · Chemico-Biological Interactions · doi:10.1016/0009-2797(90)90074-w · Cited by 14 · see citing works

Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain

Hussain, S. M., & Ali, S. F. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01158-8 · Cited by 13 · see citing works

Alterations in Multiple Tyrosine Hydroxylase mRNAs in the Substantia Nigra, Locus Coeruleus and Adrenal Gland of MPTP-treated Parkinsonian Monkeys

Ohye, T., Ichinose, H., Ogawa, M., Yoshida, M., & Nagatsu, T. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0009 · Cited by 11 · see citing works

Manganese does not alter the severe neurotoxicity of MPTP

Baek, S., Kim, Y. H., Oh, S., Lee, C.-R., Yoo, C., Lee, J. H., Lee, H., Sim, C. S., Park, J., Kim, J.-W., et al. (2007) · Human & Experimental Toxicology · doi:10.1177/0960327107070567 · Cited by 11 · see citing works

Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum

Obata, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.071 · Cited by 9 · see citing works

Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity

Rojas, P., & Klaassen, C. D. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00651-5 · Cited by 6 · see citing works

Metallothionein Isoforms Attenuate Peroxynitrite-Induced Oxidative Stress in Parkinson’s Disease

Shaik, S., Ebadi, M., Sharma, S. K., & Wanpen, S. (2004) · CRC Press eBooks · doi:10.1201/9780203508596.ch39 · Cited by 6 · see citing works

Reduction of Zinc-Positive Terminal Fields in Striatum of Mouse after 1-Methyl-4-Phenylpyridinium Neurotoxicity

Rojas, P., Franco‐Pérez, J., Rojas, C., Rojas‐Castañeda, J. C., Ebadi, M., Fernández‐Valverde, F., & Serrano‐García, N. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.04.007 · Cited by 5 · see citing works

Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum

Obata, T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.11.007 · Cited by 4 · see citing works

Neuropsychiatrische notfälle

Schapira, K. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90115-0 · Cited by 1 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

A delicate balance: Iron metabolism and diseases of the brain

Hare, D. J., Ayton, S., Bush, A. I., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 444 · see citing works

Selenium, selenoproteins and neurodegenerative diseases

Cardoso, B. R., Roberts, B. R., Bush, A. I., & Hare, D. J. (2015) · Metallomics · doi:10.1039/c5mt00075k · Cited by 295 · see citing works

Melatonin: A Versatile Protector against Oxidative DNA Damage

Galano, A., Tan, D., & Reiter, R. J. (2018) · Molecules · doi:10.3390/molecules23030530 · Cited by 290 · see citing works

Iron and dopamine: a toxic couple

Hare, D. J., & Double, K. L. (2016) · Brain · doi:10.1093/brain/aww022 · Cited by 284 · see citing works

Brain Iron Metabolism Dysfunction in Parkinson’s Disease

Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 183 · see citing works

Laser Ablation–Inductively Coupled Plasma–Mass Spectrometry Imaging in Biology

Doble, P., de Vega, R. G., Bishop, D., Hare, D. J., & Clases, D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01219 · Cited by 147 · see citing works

Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System

Kim, B.-W., Jeong, K. H., Kim, J., Jin, M., Kim, J., Lee, M., Choi, D., Won, S.-Y., McLean, C., Jeon, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4261-15.2016 · Cited by 118 · see citing works

An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta

Hare, D. J., Lei, P., Ayton, S., Roberts, B. R., Grimm, R., George, J. L., Bishop, D., Beavis, A. D., Donovan, S. J., McColl, G., et al. (2014) · Chemical Science · doi:10.1039/c3sc53461h · Cited by 114 · see citing works

Are Striatal Tyrosine Hydroxylase Interneurons Dopaminergic?

Xenias, H. S., Ibáñez-Sandoval, O., Koós, T. Z., & Tepper, J. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0195-15.2015 · Cited by 101 · see citing works

Advances in the Chemical Biology of Desferrioxamine B

Codd, R., Richardson‐Sanchez, T., Telfer, T. J., & Gotsbacher, M. P. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00851 · Cited by 103 · see citing works

Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys

Chen, M., Wang, T., Yue, F., Li, X., Wang, P., Li, Y., Chan, P., & Yu, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.003 · Cited by 103 · see citing works

Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice

Finkelstein, D. I., Hare, D. J., Billings, J. L., Sedjahtera, A., Nurjono, M., Arthofer, E., George, S., Culvenor, J. G., Bush, A. I., & Adlard, P. A. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00253 · Cited by 79 · see citing works

Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis

Guo, J., Yue, F., Song, D., Bousset, L., Liang, X., Tang, J., Yuan, L., Li, W., Melki, R., Tang, Y. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03369-x · Cited by 74 · see citing works

Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imaging

Paul, B. T., Hare, D. J., Bishop, D., Paton, C., Nguyen, V. T., Cole, N., Niedwiecki, M. M., Andreozzi, E. M., Vais, A., Billings, J. L., et al. (2015) · Chemical Science · doi:10.1039/c5sc02231b · Cited by 74 · see citing works

Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae

Kalyn, M., Hua, K., Noor, S. M., Wong, C. E. D., & Ekker, M. (2019) · Biomedicines · doi:10.3390/biomedicines8010001 · Cited by 69 · see citing works

Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease

Hare, D. J., Cardoso, B. R., Raven, E. P., Double, K. L., Finkelstein, D. I., Szymlek‐Gay, E. A., & Biggs, B. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-016-0004-y · Cited by 68 · see citing works

A brief history of brain iron accumulation in Parkinson disease and related disorders

Foley, P. B., Hare, D. J., & Double, K. L. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02505-5 · Cited by 61 · see citing works

Supramolecular Inhibition of Neurodegeneration by a Synthetic Receptor

Li, S., Chen, H., Yang, X., Bardelang, D., Wyman, I., Wan, J., Lee, S. M., & Wang, R. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00372 · Cited by 57 · see citing works

The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue

Hare, D. J., George, J. L., Bray, L., Volitakis, I., Vais, A., Ryan, T. M., Cherny, R. A., Bush, A. I., Masters, C. L., Adlard, P. A., et al. (2013) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c3ja50281c · Cited by 54 · see citing works

Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

Tai, S., Zheng, Q., Zhai, S., Cai, T., Xu, L., Yang, L., Jiao, L., & Zhang, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00612 · Cited by 50 · see citing works

Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping

Shahmaei, V., Faeghi, F., Mohammadbeigi, A., Hashemi, H., & Ashrafi, F. (2019) · European Journal of Radiology Open · doi:10.1016/j.ejro.2019.04.005 · Cited by 50 · see citing works

Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents

Chitti, S., Srinivasarao, S., Reddy, P. S. K., Trivedi, P., Bobde, Y., Kumar, C., Rangan, K., Ghosh, B., & Sekhar, K. V. G. C. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.08.013 · Cited by 48 · see citing works

Long non‐coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson’s disease cell model

Lv, K., Liu, Y., Zheng, Y., Shaowen, D., Yin, P., & Miao, H. (2021) · Biological Research · doi:10.1186/s40659-021-00332-8 · Cited by 43 · see citing works

Sirtuins as modifiers of Parkinson's disease pathology

Tang, B. L. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23806 · Cited by 40 · see citing works

Air pollutants disrupt iron homeostasis to impact oxidant generation, biological effects, and tissue injury

Ghio, A. J., Soukup, J. M., Dailey, L. A., & Madden, M. C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.007 · Cited by 39 · see citing works

From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease

Montalbán-Rodríguez, A., Abalo, R., & López‐Gómez, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021294 · Cited by 38 · see citing works

l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease

Billings, J. L., Gordon, S. L., Rawling, T., Doble, P., Bush, A. I., Adlard, P. A., Finkelstein, D. I., & Hare, D. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14676 · Cited by 38 · see citing works

Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic Mouse

Billings, J. L., Hare, D. J., Nurjono, M., Volitakis, I., Cherny, R. A., Bush, A. I., Adlard, P. A., & Finkelstein, D. I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00305 · Cited by 34 · see citing works

Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson’s disease mouse model

Zhou, Y., Zhao, W., Quan, W., Qiao, C.-M., Cui, C., Hong, H., Shi, Y. W., Niu, G.-Y., Zhao, L., & Shen, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.08.013 · Cited by 33 · see citing works

Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments

Kalyn, M., & Ekker, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.718244 · Cited by 32 · see citing works

Sex differences in the progressive model of parkinsonism induced by reserpine in rats

Bispo, J. M. M., Melo, J. E. C., de Gois, A. M., Leal, P. C., Lins, L. C. R. F., Souza, M. F., Medeiros, K. A. A. L., Ribeiro, A. M., Silva, R. H., Marchioro, M., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.041 · Cited by 31 · see citing works

Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy

Wang, D., Yang, Y., Huang, X.-S., Tang, J., Zhang, X., Huang, H., Zhou, B., Liu, B., Xiao, H., Li, X., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104972 · Cited by 31 · see citing works

Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease

Gotsbacher, M. P., Telfer, T. J., Witting, P. K., Double, K. L., Finkelstein, D. I., & Codd, R. (2017) · Metallomics · doi:10.1039/c7mt00039a · Cited by 28 · see citing works

Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?

Nikparast, F., Ganji, Z., Danesh-Doust, M., Faraji, R., & Zare, H. (2022) · Insights into Imaging · doi:10.1186/s13244-022-01207-6 · Cited by 27 · see citing works

Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

Deng, C., Zhu, J., Yuan, J., Xiang, Y., & Dai, L. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02910-5 · Cited by 24 · see citing works

On the outside looking in: redefining the role of analytical chemistry in the biosciences

Hare, D. J., & New, E. J. (2016) · Chemical Communications · doi:10.1039/c6cc00128a · Cited by 23 · see citing works

A new strategy for the treatment of Parkinson’s disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor

Qi, S., Guo, L., Liang, J., Wang, K., Liao, Q., He, S., Lyu, W., Cheng, Z., Wang, J., Luo, X., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107612 · Cited by 21 · see citing works

LINC00943 knockdown attenuates MPP+-induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells

Meng, C., Gao, J. Q., Ma, Q., Sun, Q., & Qiao, T. (2020) · Neurological Research · doi:10.1080/01616412.2020.1834290 · Cited by 21 · see citing works

Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging

Liu, T., Li, J., Wu, H., Qiao, J., & Wei, J. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101719 · Cited by 18 · see citing works

Study of Drug Delivery Using Purely Organic Macrocyclic Containers─Cucurbit[7]uril and Pillararene

Chowdhury, A. R., & Goswami, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c05465 · Cited by 17 · see citing works

Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP+-induced neurotoxicity

Rubio‐Osornio, M., Orozco‐Ibarra, M., Dı́az-Ruiz, A., Brambila, E., Boll, M., Monroy‐Noyola, A., Guevara, J., Montes, S., & Rı́os, C. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.016 · Cited by 17 · see citing works

Serum Ceruloplasmin Depletion is Associated With Magnetic Resonance Evidence of Widespread Accumulation of Brain Iron in Parkinson's Disease

Guan, X., Bai, X., Zhou, C., Guo, T., Wu, J., Gu, L., Gao, T., Wang, X., Wei, H., Zhang, Y., et al. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27680 · Cited by 17 · see citing works

Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson’s Disease

Zhang, X., Ye, Y.-L., Zhu, H., Sun, S.-N., Zheng, J., Fan, H.-H., Wu, H., Chen, S., Cheng, W., & Zhu, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163372 · Cited by 16 · see citing works

Smart antioxidant function enhancing (SAFE) nucleic acid therapy for ROS-related chronic diseases and comorbidities

Lü, Z., Zhao, R., Li, Y., Wang, J., Guo, J., Bai, C., Chen, J., Yang, J., Geng, Y., Zhang, T., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.09.004 · Cited by 14 · see citing works

Not all boronic acids with a five-membered cycle induce tremor, neuronal damage and decreased dopamine

Pérez-Rodríguez, M., García-Mendoza, E., Farfán‐García, E. D., Das, B. C., Ciprés-Flores, F. J., Trujillo-Ferrara, J. G., Cach, F. T., & Soriano-Ursua, M. A. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.06.004 · Cited by 14 · see citing works

From niche methods to necessary tools: The growing importance of analytical atomic spectrometry in metal imaging in neuroscience

McAllum, E., & Hare, D. (2019) · Spectrochimica Acta Part B - Atomic Spectroscopy · doi:10.1016/j.sab.2019.04.009 · Cited by 7 · see citing works

Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson’s Disease

Oliveira, B. D. S., Toscano, E. C. D. B., Abreu, L. K. S., Fernandes, H. D. B., Amorim, R. F., Ferreira, R. N., Machado, C. A., Carvalho, B. C., da Silva, M. C. M., de Oliveira, A. C. P., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.011 · Cited by 10 · see citing works

The Role of Selenium in Neurodegenerative Diseases

Cardoso, B. R., Hare, D. J., & Bush, A. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00003-8 · Cited by 10 · see citing works

Repurposing Simvastatin in Parkinson’s Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra

Rubio‐Osornio, M., de León, C. T. G., Montes, S., Rubio, C., Rı́os, C., Monroy‐Noyola, A., & Morales‐Montor, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310414 · Cited by 9 · see citing works

Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases

Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8 · see citing works

Tiny Fish, Big Hope: Zebrafish Unlocking Secrets to Fight Parkinson’s Disease

Manjunatha, B., Manjunath, A., Srinivasa, A., & Lee, S. J. (2025) · Biology · doi:10.3390/biology14101397 · Cited by 8 · see citing works

Role of connexins in neurodegenerative diseases (Review)

Xing, J., & Xu, C. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12034 · Cited by 7 · see citing works

Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson’s Disease Biomarkers, in Mammals

Hényková, E., Kaleta, M., Klíčová, K., González, G., Novák, O., Strnad, M., & Kaňovský, P. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00516 · Cited by 6 · see citing works

The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson’s disease

Patricio, F., Juárez-Torres, D., Patricio-Martínez, A., Mendieta, L., Pérez‐Severiano, F., Montes, S., Aguilera, J., & Limón, I. D. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.08.005 · Cited by 5 · see citing works

Noradrenergic–Dopaminergic Interactions Due to DSP-4–MPTP Neurotoxin Treatments: Iron Connection

Archer, T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_411 · Cited by 5 · see citing works

Melatonin attenuates MPP+-induced autophagy via heat shock protein in the Parkinson’s disease mouse model

Guo, Y., & Liu, C. (2025) · PeerJ · doi:10.7717/peerj.18788 · Cited by 4 · see citing works

RNA sequencing and proteomic profiling reveal alterations by MPTP in chronic stomach mucosal injury in tree shrew Chinese (Tupaia belangeri chinensis)

Wang, C.-Y., Ye, Y., Long, W.-H., Li, Z., Zheng, H. Y., Lin, X.-R., Zhou, W., & Tang, D. (2024) · Scientific Reports · doi:10.1038/s41598-023-50820-y · Cited by 4 · see citing works

Design and Synthesis of Novel Thiazole Linked Tetrahydropyridine Analogues as Anticancer Agents

Malothu, R. M., & Thalari, G. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402223 · Cited by 4 · see citing works

Induction of Ferroptotic Cell Death by Neuromelanin Pigments in Dopaminergic Cells

Kaftan, G., & Armağan, G. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00029 · Cited by 4 · see citing works

Angiotensin II Inhibits Iron Uptake and Release in Cultured Neurons

Liu, Y., Huang, S., Du, F., Yang, G., Jiang, L. R., Zhang, C., & Qian, Z. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1285-3 · Cited by 4 · see citing works

Life, death, and regeneration of zebrafish dopaminergic neurons

Hua, K., & Ekker, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817528-6.00022-x · Cited by 4 · see citing works

Neuroprotective effects of α‐melanocyte‐stimulating hormone against the neurotoxicity of 1‐methyl‐4‐phenylpyridinium

Peng, T., Wang, J., Lu, J., Lu, H., Teng, J., & Jia, Y. (2015) · IUBMB Life · doi:10.1002/iub.1385 · Cited by 4 · see citing works

Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression – A review

Gundi, B., Ho, H. L., Zhang, X., He, A., Xin, D., Ferreira, A. F. F., de Britto, L. R. G., Feng, Z., & Sun, H. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106091 · Cited by 3 · see citing works

Nanotechnology-based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders

Gadhave, D. G., Kale, V. V., Kade, A. P., Jadhav, O. R., Sugandhi, V. V., Babar, V. B., Khot, S. V., Kokare, C., & Paudel, K. R. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103026 · Cited by 3 · see citing works

Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease

Lin, T., Chiu, Y., Lin, C., Chen, Y., Lin, W., Wu, Y., Chang, K., Chen, C., & Lee‐Chen, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1437138 · Cited by 3 · see citing works

Using Tinbergen's Four Questions as the Framework for a Neuroscience Capstone Course.

Meitzen, J. (2015) · Europe PMC (PubMed Central) · Cited by 3 · see citing works

HMGA1 Regulates IRS2 to Promote Inflammatory Responses and Oxidative Stress Injury in MPP+-Induced cells

Xu, D., Fan, W., Fu, B., & Nie, H. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01510-7 · Cited by 1 · see citing works

Evaluation of novel selective MAO-B inhibitors using immobilized enzymes on magnetic beads

dos Reis, V. E. N., Franco, G. D. R. R., de Souza, M. L., da Silva, M. M. P., Guedes, I. A., Dardenne, L. E., Viegas, C., & Cardoso, C. L. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.117200 · Cited by 1 · see citing works

Imaging Metals in the Brain by Laser Ablation–Inductively Coupled Plasma-Mass Spectrometry

Hare, D. J., Paul, B. T., & Doble, P. (2017) · Neuromethods · doi:10.1007/978-1-4939-6918-0_3 · Cited by 1 · see citing works

Quercetin rescues MPP+ –induced Parkinsonian-like locomotor impairment in zebrafish larvae

Thirugnanam, T., Madhusoodanan, S., & Santhakumar, K. (2022) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2022.100314 · Cited by 1 · see citing works

Intracranial Glioblastomas: New Hope for an Effective Treatment

Cooper, A. J. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.029 · Cited by 1 · see citing works

MRI assessment of brain iron content in methamphetamine users

Berlow, Y. A. (2014) · doi:10.6083/m4028q7c

Sirtuins in mechanistic target of rapamycin complex 1 signaling

Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00012-4

Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue

Rungruang, P., Sansri, V., & Sroyraya, M. (2024) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v7i1.271

Early Detection of Parkinson's Disease through Microfluidics and Ion Mobility - Mass Spectrometry Integration

Figueiredo, I. D. (2024) · theses.fr (ABES) · doi:10.70675/e26318dazc588z42e6z90edz96ccb2ee6e71

The protein kinase B pathway as therapeutic target in neurodegenerative diseases: mechanisms and implications

Sánchez-Thomas, R., Bautista-Perez, S. M., Santana-Martínez, R. A., Silva‐Islas, C. A., Figueroa, A., Barrera‐Oviedo, D., & Maldonado, P. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00015-2

Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Sayre, L. M. (1989) · Toxicology Letters · doi:10.1016/0378-4274(89)90168-9 · Cited by 115 · see citing works

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

Gerlach, M., Riederer, P. F., Przuntek, H., & Youdim, M. B. H. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90073-q · Cited by 307 · see citing works

Metals and melanins in the extrapyramidal centers

Curzon, G. (1975) · Pharmacology & Therapeutics Part B General and Systematic Pharmacology · doi:10.1016/0306-039x(75)90023-9 · Cited by 4 · see citing works

Changes of metallothionein i + ii proteins in the brain after l-methyl-4-phenylpyridinium administration in mice

Rojas, P., Hidalgo, J., Ebadi, M., & Rı́os, C. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00077-9 · Cited by 18 · see citing works

1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

(2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_6155